PROSPECTIVE TRIAL OF CETUXIMAB PLUS IRINOTECAN FOR OXALIPLATIN AND IRINOTECAN-BASED CHEMOTHERAPY-REFRACTORY PATIENTS ADVANCED AND/OR METASTATIC COLORECTAL CANCER, EVALUATION OF THE EFFICACY AND SAFETY BASED ON MUTATION STATUS OF THE EGFR RELATED GENES

被引：0

作者：

Shimodaira, H. ^{[1
,2
]}

Soeda, H. ^{[1
,2
]}

Gamoh, M. ^{[3
]}

Andoh, H. ^{[4
]}

Yamaguchi, T. ^{[5
]}

Watanabe, M. ^{[6
]}

Ishobe, H. ^{[7
]}

Sudo, T. ^{[8
]}

Kato, S. ^{[1
,2
]}

Ishioka, C. ^{[1
,2
]}

机构：

[1] Tohoku Univ, IDAC, Dept Clin Oncol, Sendai, Miyagi 980, Japan

[2] Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan

[3] Osaki Citizen Hosp, Dept Clin Oncol, Osaka, Japan

[4] Akita Univ, Grad Sch Med, Akita 010, Japan

[5] Tohoku Univ, Grad Sch Med, Dept Med Stat, Sendai, Miyagi 980, Japan

[6] Tohoku Univ, Dept Pathol, Sendai, Miyagi 980, Japan

[7] Yamagata Univ, Yamagata 990, Japan

[8] Yamagata Pref Cent Hosp, Yamagata, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：119 / 119

页数：1